BioElectronics Corporation
BIEL
$0.0001
-$0.0001-50.00%
| 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | |
|---|---|---|---|---|---|
| Revenue | 182.20K | 414.70K | 412.60K | 600.00K | 521.80K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 182.20K | 414.70K | 412.60K | 600.00K | 521.80K |
| Cost of Revenue | 148.90K | 131.70K | 207.00K | 326.40K | 217.30K |
| Gross Profit | 33.30K | 283.00K | 205.60K | 273.60K | 304.50K |
| SG&A Expenses | -16.90K | 215.40K | 150.00K | 256.40K | 374.10K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 222.70K | 421.00K | 439.40K | 663.50K | 716.60K |
| Operating Income | -40.40K | -6.40K | -26.80K | -63.50K | -194.80K |
| Income Before Tax | -127.70K | 22.40K | -46.00K | -138.60K | -108.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -127.70K | 22.40K | -46.00K | -138.60K | -108.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -127.70K | 22.40K | -46.00K | -138.60K | -108.70K |
| EBIT | -40.40K | -6.40K | -26.80K | -63.50K | -194.80K |
| EBITDA | -- | -- | -- | -- | -194.60K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 24.55B | 24.16B | 24.16B | 24.16B | 24.67B |
| Average Diluted Shares Outstanding | 24.55B | 24.16B | 24.16B | 24.16B | 24.67B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
